Franklyn Prendergast

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Immunome Inc. publishes a filing, an earnings call transcript or a press release.

Get IMNM alerts

About Franklyn Prendergast

Franklyn Prendergast is recorded as Board Member at Immunome Inc. (IMNM) since October 2, 2023. Immunome Inc. reported in an 8-K filed October 4, 2023 that Franklyn Prendergast was appointed Class II Director, effective October 2, 2023. Immunome Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunome Inc. includes Clay B. Siegall, Ph.D. (CEO), Clay Siegall (CEO), Corleen Roche (CFO) and 7 others.

“Immediately following the effective time of the Merger, Immunome's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”

Immunome Inc. Form 8-K, filed October 4, 2023 · Read the filing

Affiliation history

Immunome Inc. (IMNM)
Board Member

SEC 8-K

Current
2023-10-02–present

Company network

Immunome Inc.

IMNM

Current role

Biotechnology · Healthcare

Board Member

2023-10-02–present

Leadership on record at Immunome Inc.

Clay B. Siegall, Ph.D. CEO
Clay Siegall CEO
Corleen Roche CFO
Diane Marcou CFO
Max Rosett CFO
Matthew K. Robinson CTO
Sandra Stoneman General Counsel
Bob Lapetina Chief Accounting Officer
Carol Schafer Board Member
Franklyn G. Prendergast, M.D., Ph.D. Board Member

Recent activity

Executive change Appointed: Class II Director Immunome Inc. (IMNM)
2023-10-02